Research
Improving antibiotics against persistent bacteria
Our lab studies the response of bacteria to antibiotics in
order to develop new methods for eradicating persistent bacteria.
Bacterial persistence is a form antibiotic resistance in which a
transient fraction of bacterial cells tolerates severe antibiotic
treatment while the majority of the population is eliminated. These
‘persisters’ can contribute to chronic infections and are a major
medical problem. Despite their medical and scientific importance,
presistence is not fully understood. A crucial challenge in studying
bacterial persistence results from a lack of methods to isolate
persisters from the heterogeneous populations in which they occur. As a
result, systems-level analysis of persisters is beyond current
techniques, and fundamental questions regarding their physiological
diversity remain unanswered. Our lab seeks to develop methods to
isolate persisters and study them with systems-wide, molecular
techniques. The resulting findings will be used to engineer
improved antibiotic therapies. Dr. Allison's previous research
included development of a novel method to eradicate pathogenic
bacteria, including Escherichia coli
and Staphylococcus aureus, by
metabolic stimulation and the finding that bacteria communicate with
each other to alter their tolerance to antibiotics.
Kyle Allison
Fellow
Department of Systems Biology
Columbia University